Review Article
Computational Vaccinology: An Important Strategy to Discover New Potential S. mansoni Vaccine Candidates
Table 1
S. mansoni tegument surface exposed proteins evaluated as vaccine targets.
| Candidate | Vaccine type | Immunologic response | Humoral response | Eggs reduction | Worms reduction | Bioinformatic tool | Ref. |
| Sm-p80 | DNA vaccine (PcDNA) | Th1a,b | IgG, IgG2a and IgG2b | 84% | 59% | ND | [31] | TSP-2 | Recombinant protein | ND | IgG, IgG1 and IgG2a | 64% (liver) 65% (feces) | 57% | BLAST | [19, 32] | Sm29 | Recombinant protein | Th1a,b | IgG, IgG1 and IgG2a anti-Sm29 | 60% (intestinal eggs) | 51% | BLAST, InterPro Scan, SignalP 3.0, SignalP Neural, NetNGlyc 1.0, WolfPSORT, SOSUI, Compute pI/Mw tool, GOR IV. | [20, 21] | ECL (200 Kda protein) | DNA vaccine | ND | IgG, IgG1 > IgG2a | ND | 38.1% | ND | [33] | Sm 25 | Peptide vaccine | ND | IgG | No significative difference with control group | No significative difference with control group | ND | [34, 35] |
|
|
ND: not determined. Sm25 were tested in mice and rats, all the others antigens were tested in mice.
|